{"schema_version":"alpha-profile-public-v1","slug":"michael-s-wyzga","canonical_url":"https://registry.alpha.ac/people/michael-s-wyzga","as_of":"2026-09-21T23:36:27.46625+00:00","published_at":"2026-09-02T02:37:20.570675+00:00","last_reviewed_at":"2026-05-16T03:29:32.411+00:00","identity":{"display_name":"Michael S. Wyzga","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Tvardi Therapeutics, Inc.","company_slug":"tvardi-therapeutics-inc","exchange":"NASDAQ","ticker":"TVRD","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-25T00:17:01.093+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=michael-s-wyzga","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=michael-s-wyzga&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Wyzga has senior management experience at biopharmaceutical and biotechnology companies with significant financial expertise. He served as President and Chief Executive Officer of Radius Health, Inc. and held multiple senior positions at Genzyme Corporation, including Executive Vice President of Finance and Chief Financial Officer. He currently serves as President of MSW Consulting Inc. and as Chairman of the board of directors at GenSight Biologics S.A. and Mereo BioPharma Group plc."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Tvardi Therapeutics, Inc.","organizationId":"tvardi-therapeutics-inc","title":"Director","period":"2025-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm"},{"organization":"Mereo BioPharma Group plc","organizationId":"mereo-biopharma-group-plc","title":"Director","period":"2019-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm"},{"organization":"X4 Pharmaceuticals, Inc","organizationId":"x4-pharmaceuticals-inc","title":"Director","period":"2018-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Tvardi Therapeutics, Inc.","company_slug":"tvardi-therapeutics-inc","exchange":"NASDAQ","ticker":"TVRD","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-25T00:17:01.093+00:00"}},{"company_name":"Mereo BioPharma Group plc","company_slug":"mereo-biopharma-group-plc","exchange":"NASDAQ","ticker":"MREO","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","effective_date":"2026-04-09","last_checked_at":"2026-04-24T23:46:00.544+00:00"}},{"company_name":"X4 Pharmaceuticals, Inc","company_slug":"x4-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"XFOR","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2018-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","effective_date":"2026-03-20","last_checked_at":"2026-04-25T00:23:00.668+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Michael S. Wyzga as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.608268+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Michael S. Wyzga currently serves as Director at Tvardi Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T17:16:39.675941+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TVRD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T17:16:39.599227+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"Michael S. Wyzga currently serves as Chair at Mereo BioPharma Group plc.","claim_state":"verified","valid_from":"2026-04-09","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:15:42.490968+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MREO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","published_at":"2026-04-09T00:00:00+00:00","last_checked_at":"2026-05-16T01:15:42.41522+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Lead Independent Director","claim_text":"Michael S. Wyzga currently serves as Lead Independent Director at X4 Pharmaceuticals, Inc.","claim_state":"verified","valid_from":"2026-03-20","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.565933+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Michael S. Wyzga serves on Audit.","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T17:16:39.698023+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TVRD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T17:16:39.599227+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit and Risk","Nomination and Corporate Governance"],"claim_text":"Michael S. Wyzga serves on Audit and Risk, Nomination and Corporate Governance.","claim_state":"verified","valid_from":"2026-04-09","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:15:42.510723+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"MREO DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","published_at":"2026-04-09T00:00:00+00:00","last_checked_at":"2026-05-16T01:15:42.41522+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Nominating/Governance"],"claim_text":"Michael S. Wyzga serves on Audit, Nominating/Governance.","claim_state":"verified","valid_from":"2026-03-20","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.588085+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"MSW Consulting Inc.","claim_text":"Michael S. Wyzga is linked to MSW Consulting Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.738167+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"President","claim_text":"Michael S. Wyzga is also listed as President.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.717202+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Michael S. Wyzga as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.651807+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Michael S. Wyzga as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:29:32.629712+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"XFOR DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","published_at":"2026-03-20T00:00:00+00:00","last_checked_at":"2026-05-16T03:29:32.482469+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:michael-s-wyzga","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2025-01-01 · current","organization":"Tvardi Therapeutics, Inc.","organization_id":"tvardi-therapeutics-inc"},"claim_text":"Director at Tvardi Therapeutics, Inc. (2025-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:michael-s-wyzga","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2019-01-01 · current","organization":"Mereo BioPharma Group plc","organization_id":"mereo-biopharma-group-plc"},"claim_text":"Director at Mereo BioPharma Group plc (2019-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:michael-s-wyzga","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2018-01-01 · current","organization":"X4 Pharmaceuticals, Inc","organization_id":"x4-pharmaceuticals-inc"},"claim_text":"Director at X4 Pharmaceuticals, Inc (2018-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/michael-s-wyzga#profile","url":"https://registry.alpha.ac/people/michael-s-wyzga","dateModified":"2026-05-16T03:29:32.411+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/michael-s-wyzga#person","name":"Michael S. Wyzga","url":"https://registry.alpha.ac/people/michael-s-wyzga","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Tvardi Therapeutics, Inc.","tickerSymbol":"NASDAQ: TVRD"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","memberOf":{"@type":"Organization","name":"Tvardi Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/tvardi-therapeutics-inc","tickerSymbol":"NASDAQ: TVRD"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","memberOf":{"@type":"Organization","name":"Mereo BioPharma Group plc","url":"https://registry.alpha.ac/companies/mereo-biopharma-group-plc","tickerSymbol":"NASDAQ: MREO"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2018-01-01","memberOf":{"@type":"Organization","name":"X4 Pharmaceuticals, Inc","url":"https://registry.alpha.ac/companies/x4-pharmaceuticals-inc","tickerSymbol":"NASDAQ: XFOR"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm","name":"XFOR DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm","name":"TVRD DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526148832/mreo-20260407.htm","name":"MREO DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/michael-s-wyzga"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":17,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":17,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":9,"distinct_source_count":3,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":17,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":17,"corroborated_claims":0,"sources":9,"distinct_sources":3,"role_claims":3,"last_reviewed_at":"2026-05-16T03:29:32.411+00:00","observed_at":"2026-09-21T23:36:27.46625+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"michael-s-wyzga","canonical_url":"https://registry.alpha.ac/people/michael-s-wyzga"},"publication":{"published_at":"2026-09-02T02:37:20.570675+00:00","last_reviewed_at":"2026-05-16T03:29:32.411+00:00","as_of":"2026-09-21T23:36:27.46625+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/michael-s-wyzga","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/michael-s-wyzga","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/michael-s-wyzga.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}